Lilly 'Disappointed' by Cancer Drug Study

Posted: Updated:
INDIANAPOLIS -

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has announced what it calls disappointing results of a study of a new cancer drug. The pharmaceutical giant says the Phase 3 study of Lartruvo, which aims to treat patients with advanced or metastatic soft tissue sarcoma, did not meet its primary endpoints.

The study involved the use of Lartruvo in combination with doxorubicin, which alone is the standard of care treatment for STS. Lilly says the study showed no difference in survival for patients involved. 

Lilly says the combination of Lartruvo and doxorubicin previously showed a benefit in a 133-patient, U.S.-only, randomized Phase 2 trial, which led to an accelerated approval by the U.S. Food and Drug Administration. The company is now working with global regulators to determine the appropriate next steps for the drug.

"Lilly was surprised and disappointed that LARTRUVO did not improve survival for patients with advanced soft tissue sarcoma in this study," said Anne White, president of Lilly Oncology. "Lilly is committed to helping people who have soft tissue sarcoma and we will carefully study the detailed data in an effort to better understand the different results between the two trials."

Lilly says it is suspending promotion of Lartruvo for the time being. The company expects to incur a charge in the first quarter related to Lartruvo, which could range from $70 million to $90 million. 

  • Perspectives

    • World Refugee Day Shines Light on Untapped Pool of Talented Workers

      From Fortune 500 companies to local small businesses, a similar theme rings true. In this strong economy where unemployment is low and growth is high, companies are competing for top talent. In Indianapolis - according to the U.S. Bureau of Labor and Statistics - unemployment is just 2.8 percent, and investment and job growth are on the rise. This is great news for Indianapolis-area residents looking for work or opportunities to advance their careers, but for businesses and...
    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Lilly Exec Named BioCrossroads CEO

      After a national search, BioCrossroads has announced Patty Martin will become the life science initiative's next president and chief executive officer. Martin, who most recently served as chief operating officer for Lilly Diabetes, will begin her new role Monday. She will become just the third CEO in the organization's 17-year history, and succeeds David Johnson, who in December announced plans to step down from the role to serve as president and CEO of the...

    • (file photo courtesy of Radial)

      Radial Opens Fulfillment Center in Brownsburg

      Pennsylvania-based Radial Inc. says its new fulfillment center in Brownsburg is now open. The e-commerce technology and operations company says the nearly 700,000-square-foot facility is the largest in its network and will have the capacity to house about 2,000 employees.

    • Holcomb will chair the 2019 conference, set for November 7 in Indianapolis.

      Janet Holcomb to Chair Conference For Women

      Indiana First Lady Janet Holcomb will serve as chair for this year's Indiana Conference for Women. Nearly 2,000 people are expected to attend the ninth annual conference, in Indianapolis in November. Holcomb's career includes a stint as vice president of her family's bolt and fastener manufacturing business, R&R Engineering. She has also led fundraising efforts for political campaigns as well as nonprofit organizations focusing in areas including animal welfare, arts and...

    • (rendering courtesy of Jones Development Co.)

      New Business Park Planned for Whiteland

      Missouri-based Jones Development Co. has begun construction on a new business park in Johnson County. The 2.4 million-square-foot Whiteland Exchange will be located on 167 acres near I-65 in Whiteland.  Financial terms of the developer's investment in the project were not disclosed. The business park is slated to include modern industrial buildings for logistics, advanced manufacturing and related uses. Work is underway on the first two speculative buildings, which total nearly...

    • Franciscan Health Details Data Breach

      Mishawaka-based Franciscan Health is providing details of a data breach. The health system says an internal investigation found one of its employees accessed the protected health information of about 2,200 patients "without a business reason."  Franciscan says the vast majority of the affected medical records was limited to demographic information such as name, address, email address, date of birth, phone number, gender, race/ethnicity, the last four digits of...